NO20091985L - 2-fenyl-6-aminokarbonyl-pyrimidinderivater - Google Patents
2-fenyl-6-aminokarbonyl-pyrimidinderivaterInfo
- Publication number
- NO20091985L NO20091985L NO20091985A NO20091985A NO20091985L NO 20091985 L NO20091985 L NO 20091985L NO 20091985 A NO20091985 A NO 20091985A NO 20091985 A NO20091985 A NO 20091985A NO 20091985 L NO20091985 L NO 20091985L
- Authority
- NO
- Norway
- Prior art keywords
- aminocarbonyl
- phenyl
- pyrimidine derivatives
- treatment
- vascular
- Prior art date
Links
- ASXFPMPUSPNUQM-UHFFFAOYSA-N 2-phenylpyrimidine-4-carboxamide Chemical class NC(=O)C1=CC=NC(C=2C=CC=CC=2)=N1 ASXFPMPUSPNUQM-UHFFFAOYSA-N 0.000 title abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940127424 P2Y12 Receptor Antagonists Drugs 0.000 abstract 1
- 208000027032 Renal vascular disease Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 230000009278 visceral effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2006053929 | 2006-10-25 | ||
| PCT/IB2007/054325 WO2008050301A2 (en) | 2006-10-25 | 2007-10-24 | 2- phenyl- 6-aminocarbonyl- pyrimidine derivatives and their use as p2y12 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091985L true NO20091985L (no) | 2009-05-22 |
Family
ID=39324985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091985A NO20091985L (no) | 2006-10-25 | 2009-05-22 | 2-fenyl-6-aminokarbonyl-pyrimidinderivater |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8044055B2 (de) |
| EP (1) | EP2079711B1 (de) |
| JP (1) | JP5144670B2 (de) |
| KR (1) | KR101434697B1 (de) |
| CN (1) | CN101528715B (de) |
| AR (1) | AR063518A1 (de) |
| AT (1) | ATE454377T1 (de) |
| AU (1) | AU2007310435A1 (de) |
| BR (1) | BRPI0717369A2 (de) |
| CA (1) | CA2664347C (de) |
| CL (1) | CL2007003038A1 (de) |
| DE (1) | DE602007004245D1 (de) |
| ES (1) | ES2339408T3 (de) |
| IL (1) | IL198334A0 (de) |
| MA (1) | MA30903B1 (de) |
| MX (1) | MX2009004186A (de) |
| NO (1) | NO20091985L (de) |
| PL (1) | PL2079711T3 (de) |
| RU (1) | RU2009119421A (de) |
| TW (1) | TW200829247A (de) |
| WO (1) | WO2008050301A2 (de) |
| ZA (1) | ZA200903574B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0758232B2 (ja) | 1991-01-23 | 1995-06-21 | 川崎重工業株式会社 | 内燃機関の出力算出方法 |
| TW200640877A (en) | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
| CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
| JP4729133B2 (ja) | 2007-11-29 | 2011-07-20 | アクテリオン ファーマシューティカルズ リミテッド | ホスホン酸誘導体及びｐ２ｙ１２受容体拮抗剤としてのそれらの使用 |
| AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
| AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
| CA2756542C (en) | 2009-04-08 | 2017-08-22 | Actelion Pharmaceuticals Ltd | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
| CA2756654C (en) | 2009-04-22 | 2017-08-22 | Actelion Pharmaceuticals Ltd | Thiazole derivatives and their use as p2y12 receptor antagonists |
| WO2013033178A1 (en) | 2011-08-30 | 2013-03-07 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
| CN102992968B (zh) * | 2012-08-15 | 2014-07-16 | 河北工业大学 | 2,3-二甲氧基-1-丙醇及其制备方法 |
| DK3515924T3 (da) | 2016-09-22 | 2022-03-21 | Idorsia Pharmaceuticals Ltd | Krystallinske former |
| SG11201908128YA (en) | 2017-03-15 | 2019-10-30 | Idorsia Pharmaceuticals Ltd | Subcutaneous administration of a p2y12 receptor antagonist |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5373586A (en) | 1976-12-09 | 1978-06-30 | Mitsubishi Chem Ind Ltd | New penicillin derivatives |
| JPS61227572A (ja) * | 1985-04-02 | 1986-10-09 | Ishihara Sangyo Kaisha Ltd | Ｎ−ベンゾイル−ｎ′−ピリミジニルオキシフエニルウレア系化合物及びそれらを含有する抗癌剤 |
| ES2248084T3 (es) | 1999-06-14 | 2006-03-16 | Eli Lilly And Company | Inhibidores de serinproteasa. |
| US6861424B2 (en) | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
| CN1181062C (zh) * | 2001-12-28 | 2004-12-22 | 陈依军 | 2－苯氧基嘧啶衍生物及其治疗用途 |
| EA200500899A1 (ru) | 2002-12-11 | 2006-02-24 | Шеринг Акциенгезельшафт | Антагонисты аденозиндифосфатного рецептора тромбоцитов |
| TW200640877A (en) * | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
| CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
| JP4729133B2 (ja) | 2007-11-29 | 2011-07-20 | アクテリオン ファーマシューティカルズ リミテッド | ホスホン酸誘導体及びｐ２ｙ１２受容体拮抗剤としてのそれらの使用 |
| AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
| AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
| CA2756542C (en) | 2009-04-08 | 2017-08-22 | Actelion Pharmaceuticals Ltd | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
| CA2756654C (en) | 2009-04-22 | 2017-08-22 | Actelion Pharmaceuticals Ltd | Thiazole derivatives and their use as p2y12 receptor antagonists |
-
2007
- 2007-10-23 AR ARP070104678A patent/AR063518A1/es unknown
- 2007-10-23 CL CL200703038A patent/CL2007003038A1/es unknown
- 2007-10-24 AT AT07826850T patent/ATE454377T1/de active
- 2007-10-24 DE DE602007004245T patent/DE602007004245D1/de active Active
- 2007-10-24 EP EP07826850A patent/EP2079711B1/de active Active
- 2007-10-24 US US12/447,039 patent/US8044055B2/en active Active
- 2007-10-24 CN CN2007800399452A patent/CN101528715B/zh not_active Expired - Fee Related
- 2007-10-24 AU AU2007310435A patent/AU2007310435A1/en not_active Abandoned
- 2007-10-24 BR BRPI0717369-5A2A patent/BRPI0717369A2/pt not_active IP Right Cessation
- 2007-10-24 MX MX2009004186A patent/MX2009004186A/es active IP Right Grant
- 2007-10-24 WO PCT/IB2007/054325 patent/WO2008050301A2/en not_active Ceased
- 2007-10-24 KR KR1020097009600A patent/KR101434697B1/ko not_active Expired - Fee Related
- 2007-10-24 TW TW096139907A patent/TW200829247A/zh unknown
- 2007-10-24 RU RU2009119421/04A patent/RU2009119421A/ru not_active Application Discontinuation
- 2007-10-24 JP JP2009534029A patent/JP5144670B2/ja not_active Expired - Fee Related
- 2007-10-24 ES ES07826850T patent/ES2339408T3/es active Active
- 2007-10-24 CA CA2664347A patent/CA2664347C/en active Active
- 2007-10-24 PL PL07826850T patent/PL2079711T3/pl unknown
-
2009
- 2009-04-23 IL IL198334A patent/IL198334A0/en unknown
- 2009-05-15 MA MA31890A patent/MA30903B1/fr unknown
- 2009-05-22 NO NO20091985A patent/NO20091985L/no not_active Application Discontinuation
- 2009-05-22 ZA ZA200903574A patent/ZA200903574B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200829247A (en) | 2008-07-16 |
| KR20090068278A (ko) | 2009-06-25 |
| JP5144670B2 (ja) | 2013-02-13 |
| WO2008050301A2 (en) | 2008-05-02 |
| CL2007003038A1 (es) | 2008-06-06 |
| JP2010507646A (ja) | 2010-03-11 |
| CN101528715A (zh) | 2009-09-09 |
| US8044055B2 (en) | 2011-10-25 |
| MA30903B1 (fr) | 2009-11-02 |
| ATE454377T1 (de) | 2010-01-15 |
| ZA200903574B (en) | 2010-08-25 |
| AU2007310435A1 (en) | 2008-05-02 |
| ES2339408T3 (es) | 2010-05-19 |
| AR063518A1 (es) | 2009-01-28 |
| RU2009119421A (ru) | 2011-04-27 |
| DE602007004245D1 (de) | 2010-02-25 |
| KR101434697B1 (ko) | 2014-08-27 |
| CA2664347C (en) | 2014-10-21 |
| EP2079711B1 (de) | 2010-01-06 |
| US20090291962A1 (en) | 2009-11-26 |
| EP2079711A2 (de) | 2009-07-22 |
| MX2009004186A (es) | 2009-05-11 |
| BRPI0717369A2 (pt) | 2014-10-07 |
| CN101528715B (zh) | 2011-08-24 |
| CA2664347A1 (en) | 2008-05-02 |
| IL198334A0 (en) | 2010-02-17 |
| WO2008050301A3 (en) | 2008-10-09 |
| PL2079711T3 (pl) | 2010-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091985L (no) | 2-fenyl-6-aminokarbonyl-pyrimidinderivater | |
| NO20091838L (no) | 2-aminokarbonyl-pyridinderivater | |
| NO20076094L (no) | Pyrimidine derivatives and their use as p2y12 receptor antagonists | |
| MX2010005519A (es) | Derivados de acido fosfonico y su uso como antagonista del receptor p2 y12. | |
| WO2010116328A3 (en) | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adp receptor antagonists | |
| CY2024025I2 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ 1,2,3,4- ΤΕΤΡΑΫΔΡΟΚΥΚΛΟΠΕΝΤΑ[b]ΙΝΔΟΛ-3-ΥΛ-ΟΞΙΚΟΥ ΟΞΕΟΣ ΧΡΗΣΙΜΑ ΣΤΗΝ ΑΓΩΓΗ ΑΥΤΟΑΝΟΣΩΝ ΚΑΙ ΦΛΕΓΜΟΝΩΔΩΝ ΔΙΑΤΑΡΑΧΩΝ | |
| WO2010030813A3 (en) | Methods for inhibiting ocular angiogenesis | |
| LT2894165T (lt) | Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui | |
| NO20092470L (no) | Substituerte diazepanforbindelser som orexinreseptorantagonister | |
| DE602007008434D1 (de) | Rezeptoren | |
| DK2152690T3 (da) | Pyridylpiperidinorexin-receptorantagonister | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| CL2012000591A1 (es) | Compuestos derivados de pirimidina o 1,3,5-triazina, antagonistas de hepcidina; composicion farmaceutica; combinacion farmaceutica util en el tratamiento de desordenes del metabolismo del hierro y los sintomas asociados. | |
| MA32975B1 (fr) | Antagonistes de c5ar | |
| MA33277B1 (fr) | Dérivés de thiazole et leur utilisation comme antagonistes des récepteurs p2y12 | |
| FR23C1002I1 (fr) | 2,4,6-trifluoro-n-ý6-(l-méthyl-pipéridin-4- carbonyl)-pyridin-2-yl]-benzamide destiné au traitement de la migraine par la voie orale ou intraveineuse | |
| EP2192920A4 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von strahlungsinduzierter fibrose | |
| WO2010030891A3 (en) | Aryl guanidine f1f0-atpase inhibitors and related methods | |
| BRPI0819434A2 (pt) | método de tratamento ou prevenção de doenças hepáticas e uso de antagonistas á angiogênese em condições de proliferação venosa anormal | |
| MA32277B1 (fr) | Derives de 2-phenyl-4- cyclopropyl-pyrimidine | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| MA32224B1 (fr) | Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales | |
| CL2008000982A1 (es) | Compuestos derivados de 5-oxo-isoxazol-carboxamida; proceso de preparacion; composicion farmaceutica; procedimiento de produccion de la composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos ateroscleroticos, de metabolismo de | |
| CO6290689A2 (es) | Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica | |
| MX2008009161A (es) | Tratamiento de enfermedad cardiovascular en mexicano-americanos, usando nebivolol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |